- Home
- CEV vs PMVP Comparison
CEV vs PMVP Comparison
Compare CEV & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CEV
- PMVP
- Stock Information
- Founded
- CEV 1999
- PMVP 2013
- Country
- CEV United States
- PMVP United States
- Employees
- CEV N/A
- PMVP N/A
- Industry
- CEV Finance/Investors Services
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- CEV Finance
- PMVP Health Care
- Exchange
- CEV Nasdaq
- PMVP Nasdaq
- Market Cap
- CEV 66.8M
- PMVP 77.4M
- IPO Year
- CEV N/A
- PMVP 2020
- Fundamental
- Price
- CEV $9.91
- PMVP $1.23
- Analyst Decision
- CEV
- PMVP Strong Buy
- Analyst Count
- CEV 0
- PMVP 1
- Target Price
- CEV N/A
- PMVP $5.00
- AVG Volume (30 Days)
- CEV 19.6K
- PMVP 2.5M
- Earning Date
- CEV 01-01-0001
- PMVP 11-06-2025
- Dividend Yield
- CEV 4.23%
- PMVP N/A
- EPS Growth
- CEV N/A
- PMVP N/A
- EPS
- CEV 0.36
- PMVP N/A
- Revenue
- CEV N/A
- PMVP N/A
- Revenue This Year
- CEV N/A
- PMVP N/A
- Revenue Next Year
- CEV N/A
- PMVP N/A
- P/E Ratio
- CEV $29.36
- PMVP N/A
- Revenue Growth
- CEV N/A
- PMVP N/A
- 52 Week Low
- CEV $8.83
- PMVP $0.81
- 52 Week High
- CEV $10.91
- PMVP $1.84
- Technical
- Relative Strength Index (RSI)
- CEV 74.13
- PMVP 39.98
- Support Level
- CEV $9.45
- PMVP $1.19
- Resistance Level
- CEV $10.01
- PMVP $1.84
- Average True Range (ATR)
- CEV 0.06
- PMVP 0.16
- MACD
- CEV 0.05
- PMVP -0.03
- Stochastic Oscillator
- CEV 81.58
- PMVP 6.15
About CEV Eaton Vance California Municipal Income Trust Shares of Beneficial Interest
Eaton Vance CA Muni Income Trust is a non-diversified closed-end investment company. The company's investment objective is to provide current income exempt from regular federal income tax and California state personal income taxes. It invests in municipal obligations, issued by the State of California or its political subdivisions, agencies, authorities and instrumentalities and also has some exposure to corporate bonds.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.